SQZ vs. CISS, PSIG, USDP, MOND, AIRTP, ATCOL, BLDEW, RA, IMPPP, and PXSAW
Should you be buying SQZ Biotechnologies stock or one of its competitors? The main competitors of SQZ Biotechnologies include C3is (CISS), PSI Group (PSIG), USD Partners (USDP), Mondee (MOND), Air T (AIRTP), Atlas (ATCOL), Blade Air Mobility (BLDEW), Brookfield Real Assets Income Fund (RA), Imperial Petroleum (IMPPP), and Pyxis Tankers (PXSAW). These companies are all part of the "transportation" industry.
SQZ Biotechnologies vs.
SQZ Biotechnologies (NYSE:SQZ) and C3is (NASDAQ:CISS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, community ranking, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation.
SQZ Biotechnologies has a beta of 2.34, meaning that its share price is 134% more volatile than the S&P 500. Comparatively, C3is has a beta of 1.61, meaning that its share price is 61% more volatile than the S&P 500.
In the previous week, C3is' average media sentiment score of 0.63 beat SQZ Biotechnologies' score of 0.00 indicating that C3is is being referred to more favorably in the news media.
C3is has a net margin of 5.74% compared to SQZ Biotechnologies' net margin of -369.96%. C3is' return on equity of 19.35% beat SQZ Biotechnologies' return on equity.
C3is has higher revenue and earnings than SQZ Biotechnologies. C3is is trading at a lower price-to-earnings ratio than SQZ Biotechnologies, indicating that it is currently the more affordable of the two stocks.
SQZ Biotechnologies received 10 more outperform votes than C3is when rated by MarketBeat users.
38.5% of SQZ Biotechnologies shares are held by institutional investors. Comparatively, 10.5% of C3is shares are held by institutional investors. 16.0% of SQZ Biotechnologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Summary
C3is beats SQZ Biotechnologies on 8 of the 13 factors compared between the two stocks.
Get SQZ Biotechnologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for SQZ and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SQZ Biotechnologies Competitors List
Related Companies and Tools
This page (NYSE:SQZ) was last updated on 5/24/2025 by MarketBeat.com Staff
Buy SQZ Stock Free SQZ Stock Alerts